Lexaria Bioscience Corp. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINEEFFECTLexaria Bioscience Corp.LEXX5d

   Lexaria Bioscience Corp. filed Form S-3

   • Filed on October 13, 2026
   • Form S-3 submitted
   • CIK: 0001348362
2. ROUTINE424B3Lexaria Bioscience Corp.LEXX5d

   Lexaria Bioscience Corp. files prospectus for 923,827 shares

   • 923,827 shares of common stock for resale by selling stockholders
   • Includes 453,969 shares from Series A Warrants and 453,969 from Series B Warrants
   • 15,889 shares from placement agent warrants
3. ROUTINES-3Lexaria Bioscience Corp.LEXXOct 2

   Lexaria Bioscience files S-3 for stock resale

   • Form S-3 filed on 2026-10-02
   • 923,827 shares of common stock registered
   • Warrants may generate $11,760,182 in proceeds
4. ROUTINE8-KLexaria Bioscience Corp.LEXXWSep 9

   Current report

5. ROUTINE8-KLexaria Bioscience Corp.LEXXWSep 2

   Current report

6. ROUTINE8-KLexaria Bioscience Corp.LEXXAug 17

   Current report

7. ROUTINE8-KLexaria Bioscience Corp.LEXXWAug 10

   Current report

8. ROUTINE8-KLexaria Bioscience Corp.LEXXJul 30

   Current report

9. NOTABLE10-QLexaria Bioscience Corp.LEXXJul 13

   Quarterly report

10. NOTABLE10-QLexaria Bioscience Corp.LEXXApr 13

    Quarterly report

11. ROUTINE4Lexaria Bioscience Corp.LEXXMar 18

    Christopher Bunka, insider filing for LEXX

    Christopher Bunka, reporting

12. ROUTINE8-KLexaria Bioscience Corp.LEXXFeb 6

    Current report

13. ROUTINE8-KLexaria Bioscience Corp.LEXXWJan 28

    Current report

14. ROUTINES-8Lexaria Bioscience Corp.LEXXWJan 28

    Employee stock plan registration

15. ROUTINEEFFECTLexaria Bioscience Corp.LEXXWJan 15

    Registration declared effective

16. ROUTINE424B3Lexaria Bioscience Corp.LEXXWJan 14

    Securities offering

17. NOTABLE25-NSELexaria Bioscience Corp.LEXXWJan 14

    Delisting notice

    Nasdaq Stock Market LLC, filed by

18. NOTABLE10-QLexaria Bioscience Corp.LEXXWJan 13

    Quarterly report

19. ROUTINES-3Lexaria Bioscience Corp.LEXXWDec 29, 2025

    Securities offering

20. ROUTINE8-KLexaria Bioscience Corp.LEXXWDec 16, 2025

    Current report

21. ROUTINE424B5Lexaria Bioscience Corp.LEXXWDec 16, 2025

    Securities offering

22. ROUTINEDEF 14ALexaria Bioscience Corp.LEXXWDec 10, 2025

    Proxy statement

23. ROUTINEEFFECTLexaria Bioscience Corp.LEXXWDec 10, 2025

    Registration declared effective

24. ROUTINE424B3Lexaria Bioscience Corp.LEXXWDec 9, 2025

    Securities offering

25. ROUTINEEFFECTLexaria Bioscience Corp.LEXXWDec 9, 2025

    Registration declared effective

26. ROUTINEPOS AMLexaria Bioscience Corp.LEXXWDec 5, 2025

    POS AM filing

27. ROUTINES-1/ALexaria Bioscience Corp.LEXXWDec 5, 2025

    Securities offering (amended)

Older filings on EDGAR